Basov Gene
- SEC CIK
- 0001833516
No open-market purchases or sales filed in the past year.
Current role at each company
- Stone Point Credit Income FundChief Financial Officeras of Jan 27, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Basov Gene as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 (view filing) | Jan 23 | 4 days | Basov GeneChief Financial Officer | PPurchaseCommon Shares, par value $0.001 per share | +2.08K | $25.00 | +$51.9K | New position2.08K after | |
| Jan 27, 2025 (view filing) | Jan 23 | 4 days | Basov GeneChief Financial Officer | PPurchaseCommon Shares, par value $0.001 per share | +4.00K | $25.00 | +$100.0K | +192.5%6.08K after |